• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

    3.830 +0.140 (+3.79%)
    Streaming Delayed Price Updated: 10:22 AM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cabaletta Bio, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    News headline image
    Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... 
    Via Benzinga
    News headline image
    Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday ↗
    U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    News headline image
    Analyst Ratings for Cabaletta Bio ↗
     
    Via Benzinga
    Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/23
    Via Investor Brand Network
    Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/18
    Via Investor Brand Network
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗
     
    Via Benzinga
    News headline image
    The 7 Most Promising Momentum Stocks to Own Now ↗
    These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility. 
    Via InvestorPlace
    News headline image
    HC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know ↗
     
    Via Benzinga
    News headline image
    Why Shares of Cabaletta Bio Are Up Tuesday ↗
    The biotech stock rose after an analyst upgrade. 
    Via The Motley Fool
    Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/18
    Via Investor Brand Network
    News headline image
    Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
    From Cabaletta Bio
    Via GlobeNewswire
    Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/12
    Via Investor Brand Network
    Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/18
    Via Investor Brand Network
    News headline image
    Analyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach ↗
    Guggenheim Securities initiated coverage of Cabaletta Bio Inc (NASDAQ: CABA) with a Buy rating and  
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023 ↗
     
    Via Benzinga
    News headline image
    SPOT Stock Alert: Spotify Moves on Analyst Upgrade ↗
    Spotify (SPOT) stock is moving on Wednesday following an upgrade and price target from Wolfe Research analyst Zach Morrissey. 
    Via InvestorPlace
    News headline image
    Why Is Cabaletta Bio (CABA) Stock Down 8% Today? ↗
    Cabaletta Bio (CABA) stock is falling on Wednesday following news of insider selling at the targeted cell therapy company. 
    Via InvestorPlace
    News headline image
    Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket ↗
    Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares gained 110.8% to $1.56 in pre-market trading after the company signed a Letter of Intention with UAE-Based e-script medicine management... 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning! 
    Via InvestorPlace
    News headline image
    La-Z-Boy, FedEx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. Zura Bio Limited (NASDAQ: ZURA) shares tumbled 7.7% to $11.82 in... 
    Via Benzinga
    News headline image
    Cabaletta Bio to Present at the Jefferies Healthcare Conference
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio Announces Pricing of Public Offering of Common Stock
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Cabaletta Bio Announces Proposed Public Offering of Common Stock
    From Cabaletta Bio
    Via GlobeNewswire
    News headline image
    Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday ↗
    U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    News headline image
    Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
    Via Benzinga
    News headline image
    Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
    From Cabaletta Bio
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.